Rogel Cancer Center | University of Michigan — Ann Arbor, Michigan

Rogel Cancer Center | University of Michigan is a clinical research site located in Ann Arbor, Michigan, United States 48109-0944.

Crixeo Health Trust Score: 48/100 (POOR). This profile has not yet been claimed by the site owner.

Rogel Cancer Center | University of Michigan has participated in 1 clinical trials.

Therapeutic areas: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8.

Sponsors: Blue Note Therapeutics.

Sponsor Feasibility Report

Trust Score: 48/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rogel Cancer Center | University of Michigan?

Rogel Cancer Center | University of Michigan has a Crixeo Trust Score of 48/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rogel Cancer Center | University of Michigan conducted?

Rogel Cancer Center | University of Michigan has 1 clinical trials on record. Their work covers Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8.

Is Rogel Cancer Center | University of Michigan accredited by Crixeo Health?

Rogel Cancer Center | University of Michigan has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rogel Cancer Center | University of Michigan?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.